Michigan Kidney Translational Med. Core (MiKTMC)

@MiKTMC

Kretzler Lab(MiKTMC) goal is integrated systems biology analysis of renal disease to better understand disease and improve outcomes.

Vrijeme pridruživanja: veljača 2018.

Tweetovi

Blokirali ste korisnika/cu @MiKTMC

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MiKTMC

  1. Prikvačeni tweet

    Prevalence of Chronic Kidney Disease(CKD) is 14%; patient awareness < 10% & CKD often has no symptoms & undetected til its advanced. Get regular check-ups. Finally, support basic and clinical research to help advance our understanding & find new therapies

    Poništi
  2. Poništi
  3. 13. pro 2019.

    Great 3 days of talks by Dr Mathias Kretzler, ending with Atuk Lectureship ; Showcasing the future of Kidney research & patient care, Kidney Precision Medicine Project . Amazing volume of high quality work. Thank you for sharing resources with the community.

    Poništi
  4. Stop by poster INFO-10 this morning at to learn more about the NEPTUNE project!

    Poništi
  5. Come learn more about our O’Brien Kidney Translational Core Center - including opportunities for funding! Now at the informational posters.

    Poništi
  6. 6. stu 2019.

    A Multimodal and Integrated Approach to Interrogate Human Kidney Biopsies with Rigor and Reproducibility: The Kidney Precision Medicine Project

    Poništi
  7. Dr. Matthias Kretzler of presenting about the goals of at

    Poništi
  8. Dr. Kretzler presenting this morning at about using data integration to match patients to trials

    Poništi
  9. “This is a momentous time for our patients with nephrotic syndrome where we finally have new treatments to test,” said Dr. Matthias Kretzler, who leads the NEPTUNE study that just received a third five-year cycle of funding. Read more:

    Poništi
  10. Proud to say the machine learning pre-course at this year's is sold out! It's going to be a great course and I'm excited to see many of you there! Thanks especially to my co-directors Matthias Kretzler and .

    Poništi
  11. 9. ruj 2019.

    (2/x) Matthias Kretzler () notes the majority of funded ancillary studies w/NEPTUNE data were led by non-NEPTUNE investigators. But we hope that even more people use NEPTUNE resources. An easy 1st place to for all things is

    Poništi
  12. Evan Der and colleagues with applied scRNA-seq to LN to deconstruct its heterogeneity and identify novel targets for personalized approaches to therapy.

    Poništi
  13. Poništi
  14. 9. srp 2019.

    How do work and why are they important? 💉 Find out in episode 1 of our new podcast 'Population Healthy' (out now!), feat. , , experts. Apple: ⬅️ Spotify: ⬅️ Web: ⬅️

    , , i još njih 5
    Poništi
  15. Fervenza and colleagues with found that rituximab was noninferior to cyclosporine in inducing complete or partial remission of proteinuria at 12 months and was superior in maintaining proteinuria remission up to 24 months.

    , , i još njih 2
    Poništi
  16. Dr. Kretzler from talking about how the Nephrotic Syndrome Research Network is revolutionizing the field of glomerular kidney disease research since its inception in 2009.

    Poništi
  17. NEPTUNE with showed lower expression of the renoprotective factor DCXR in renal tissue is associated with more severe disease and worse outcome in human CKD.

    Poništi
  18. Arazi et al with revealed 21 subsets of leukocytes active in disease representing the immune cell landscape in kidneys of patients with lupus nephritis.

    , , i još njih 2
    Poništi
  19. This finding from and colleague suggests that for people with normal or elevated GFR, increasing albuminuria may better than early GFR decline in reflecting the risk of progressive type 2 diabetic nephropathy.

    Poništi
  20. Taroni et al with decribe MultiPLIER: A Transfer Learning Framework for Transcriptomics Reveals Systemic Features of Rare Diseases

    Poništi
  21. AMP RA/SLE Consortium with applied scRNA-seq to lupus ephritis (LN) to deconstruct its heterogeneity and identify novel targets for personalized approaches to therapy.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·